# A Comparative Analysis of 4% Chlorhexidine Versus Methylated Spirit as Prophylaxis of Omphalitis and Sepsis in Newborns

> **NCT06002295** · PHASE2 · COMPLETED · sponsor: **Sheikh Zayed Federal Postgraduate Medical Institute** · enrollment: 300 (actual)

## Conditions studied

- Neonatal Sepsis
- Omphalitis

## Interventions

- **DRUG:** Chlorhexidine Topical Cream
- **DRUG:** Methylated Spirit

## Key facts

- **NCT ID:** NCT06002295
- **Lead sponsor:** Sheikh Zayed Federal Postgraduate Medical Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-12
- **Primary completion:** 2021-09-22
- **Final completion:** 2021-11-19
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2023-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06002295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06002295, "A Comparative Analysis of 4% Chlorhexidine Versus Methylated Spirit as Prophylaxis of Omphalitis and Sepsis in Newborns". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06002295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*